Andrew Clegg

geriatrician, eFI, CARE75+, HERO trial, PROSPER study

[National Institute for Health and Care Research @NIHRresearch]

From today 10 NIHR Applied Research Collaborations (ARCs) will be delivering applied health and care research across England. They will be developing new treatments and technologies and supporting Government health plans. 👇

🔗 https://t.co/ZIcIZNmUlN

[NIHR Yorkshire & Humber ARC @NIHR_ARC_YH]

🚀 The next phase of @NIHR_ARC_YH starts NOW

One priority: IMPACT

Research that transforms. Partnerships that deliver. Change where it's needed most. 💙 Let's make this next phase a powerful force for positive change.

#ARCYorkshireHumber #HealthResearch #NIHR #NIHR20

[Lin Gong @GongLin_edu]

A really meaningful day at the Leeds BME Dementia Forum 2026 💛

Together with partners, we brought together 60+ people from diverse local communities, with 15 organisations involved.

Listening, sharing, and connecting.

@NIHR_ARC_YH, @alzheimerssoc @TBmedementia, @AUASResearch

[David Spiegelhalter @d_spiegel]

I was so pleased to be part of a great team writing a commentary on the draft FDA guidelines on Bayesian clinical trial designs. Should have been done 30 years ago, but better late than never

[National Institute for Health and Care Research @NIHRresearch]

We’ve announced the latest cohort of NIHR Senior Investigators, reflecting the breadth of modern research leadership.

For the first time, the cohort includes two senior research leaders from Northern Ireland, alongside increased representation from post-1992 universities.

Senior Investigators are among NIHR’s most influential researchers, driving innovation, mentoring future leaders, and shaping policy and practice.

Learn more about this year's cohort.👉https://t.co/S5XIo2XqMe

[HERO trial @HEROtrial]

HERO trial results published in Age & Ageing: https://t.co/xKdWChkSUN.
Extended rehab after acute hospital admission for older people with frailty: Reduced hospital admissions over 12 months, but did not impact measures of function or health related quality of life.

[NIHR Yorkshire & Humber ARC @NIHR_ARC_YH]

That's a wrap on a brilliant day in York! 🏛️ Thank you to all our speakers, chairs and attendees for a thought-provoking event on the future of mental health prevention in the NHS. #JourneyToPrevention2026 #NIHRYHARC

[Alasdair MacLullich @A_MacLullich]

The modified Richmond Agitation and Sedation Scale (mRASS)

For ongoing monitoring for new onset #delirium in inpatients.

[Liam Barrett @126Liam]

Really pleased to see this paper published. It should be a helpful read for anyone considering starting a clinical academic career through a post such as an ACF (not the only route into research), those currently in post, and also for supervisors/funders supporting these roles.

[NIHR ARC East Midlands @ARC_EM]

2/6 Professor Elizabeth Orton, Theme Lead and Consultant in Public Health

Practical steps to commission and expand Falls Management Exercise (FaME) despite complex funding systems. Proven to reduce falls.

Read here:
🔗 https://t.co/9oxDsRgu1r

[Ariela Orkaby MD MPH @DrAROrkaby]

Delighted to share our @AnnalsofIM review on Frailty - including practical tips for inpatient and outpatient care: https://t.co/bPznLM2Jyo
@WHOCenterFrailt @FrailtyMD @MassGenBrigham @VABostonHC @DrDamluji @GlobalFrailty @AaronTroyMD @agingdoc1 @ClinSTARCC

[Andrew Clegg @drandyclegg]

@ashetabulum @Richard_D_Riley Hi Ashar. It will be made available shortly - think the @NIHR_ARC_YH team can send a link. It was a fantastic talk from @Richard_D_Riley !!

[Academic Unit for Ageing and Stroke Research @AUASResearch]

📢 ACMICS study is now open!
We’re excited to begin this important @NIHRresearch funded project.
ACMICS aims to support safer prescribing for older adults in hospital—particularly those at risk of delirium and falls due to anticholinergic medicines.

🔗 https://t.co/DpGskXDGtP

[NIHR Yorkshire & Humber ARC @NIHR_ARC_YH]

How does a personal interest in the Electronic Frailty Index (eFI) lead to shaping major healthcare research? 🧐
Read David Smith’s inspiring journey from PPIE member to a key voice in our INCLUDE study.

Read more: https://t.co/V1g4PJtO2b

[HERO trial @HEROtrial]

HERO Trial results: https://t.co/O8wHM9Lsro Extended rehab welcomed by participants and therapists and reduced hospital admissions, but no effect on self-reported function or health related quality of life! Website:https://t.co/IntY1Gc9QC @drandyclegg

[Prof Chris P Gale @cpgale3]

Total costs of CVD in the UK in 2021/22 were £29 billion

Direct costs were:

💷 inpatient £6.7 bn;
💷 long-term £4.6 bn;
💷 meds £1.9 bn;
💷 primary care £1.6 bn;
💷 outpatient £1.0 bn;
💷 emergency £327.6 million; &
💷 medical devices £404.4 million.

https://t.co/IuEmJmVEdE

[The BMJ @bmj_latest]

Research methods and reporting: How to align eligibility and treatment assignment at time zero when emulating a target trial.

This article provides methodological guidance when emulating a target trial with longitudinal observational data
@FuEdouard
https://t.co/8vxczaTkil

[NIHR Yorkshire & Humber ARC @NIHR_ARC_YH]

📣Don't miss the 3rd webinar in our series: An Introduction to IPDMA Methods, presented by Professor Richard Riley (Professor of Biostatistics at the University of Birmingham)

📅 Date: 28th January 2026
🕛 Time: 12:00 – 13:00
�� Zoom

🔗https://t.co/koRQD6gkyf

[British Geriatrics Society @GeriSoc]

This year, we have significantly expanded our elearning offering, introducing a course on continence and a whole new series of Microlearning courses. Our elearning had a whopping 16k unique users in 2025, and we have great things planned for 2026. https://t.co/qlbpu8C0uN

[British Geriatrics Society @GeriSoc]

2025 has been a good year for @Age_and_Ageing, our international clinical geriatrics journal. The journal received a 7.1 impact factor (up from 6.0), and published the Electronic Frailty Index 2 (eFI2), an update to the highly influential eFI. Learn more: https://t.co/UnzdTZ3FT6